Skip to main content
Edgar Engleman, MD, Pathology, Palo Alto, CA, Stanford Health Care

EdgarGeorgeEnglemanMD

Pathology • Palo Alto, CA

Blood Banking & Transfusion Medicine

Professor, Pathology, Stanford University Medical Center

Join to view full profile

Are you Dr. Engleman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 42 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Edgar Engleman, MD is a pathologist in Palo Alto, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care and is a Professor at Stanford University Medical Center.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1972 - 1973
  • Camarillo State Hospital
    Camarillo State HospitalInternship, Internal Medicine, 1971 - 1972
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1982

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Cancer Cells in Lymph Nodes Crib an ‘All Access’ Pass to Metastasize, Stanford Researchers Find
    Cancer Cells in Lymph Nodes Crib an ‘All Access’ Pass to Metastasize, Stanford Researchers FindAugust 16th, 2022
  • In Memoriam: Samuel Strober, MD
    In Memoriam: Samuel Strober, MDApril 15th, 2022
  • Samuel Strober, Pioneering Transplantation Immunologist, Dies at 81
    Samuel Strober, Pioneering Transplantation Immunologist, Dies at 81March 31st, 2022
  • Join now to see all

Grant Support

  • Role Of Functionally Distinct Dendritic Cell Subsets In Tolerance And GVHDNational Heart, Lung, And Blood Institute2010–2011
  • Immune Assay, Flow Cytometry And Gene ProfilingNational Heart, Lung, And Blood Institute2010–2011
  • ImmunologyNational Cancer Institute2010–2011
  • Biology And Immunology Of Pancreatic Cancer Stem Cells In A Novel Mouse ModelNational Cancer Institute2009–2011
  • Prog 7- Cancer Immunology And ImmunotherapyNational Cancer Institute2007–2009
  • Langerhans Cell Replacement Following Allogenic Stem Cell TransplantationNational Heart, Lung, And Blood Institute2007–2008
  • Immune Assay And Flow Cytometry CoreNational Heart, Lung, And Blood Institute2007–2008
  • Dendritic Cell-Nk T Cell Interactions In The SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2007
  • Langerhans Cell Replacement After Stem Cell TransplantNational Heart, Lung, And Blood Institute2004–2006
  • Iimmune Assay And Flow Cytometry CoreNational Heart, Lung, And Blood Institute2004–2006
  • Novel Transfusion Based Immune ModulationNational Heart, Lung, And Blood Institute1997–2006
  • Role Of Ctla 4 In Immune Tolerance In HumansNational Cancer Institute2001–2003
  • Dendritic Cell Immunotherapy For Colorectal CancerNational Heart, Lung, And Blood Institute2002
  • Core--Flow CytometryNational Heart, Lung, And Blood Institute1997–2002
  • Phase I Of Flt3l Mobilized Dendritic Cell For Lung &Colon CancerNational Center For Research Resources1999–2001
  • Dendritic Cell Therapy For Prostate CancerNational Center For Research Resources1998–2001
  • Transfusion Based Immunotherapy For Colorectal CancerNational Heart, Lung, And Blood Institute1997–2001
  • Dendritic Cell Based Vaccination For Multiple MyelomaNational Center For Research Resources1997–1999
  • Use Of Altered Peptide Ligands In The Treatment Of DiabetesNational Institute Of Allergy And Infectious Diseases1996–1999
  • Dendritic Cell Based Vaccination For Prostate CancerNational Cancer Institute1996–1999
  • Cytotoxic T-Cell Epitopes Of Mycobacterium TuberculosisNational Institute Of Allergy And Infectious Diseases1993–1996
  • Therapeutic Application &Immunology Of HIV NontargetsNational Institute Of Allergy And Infectious Diseases1994–1995
  • Regulatory Lymphocytes Of The Human MLRNational Cancer Institute1993–1995
  • Therapeutic Application &Immu. Of Non-Targets Of HIVNational Institute Of Allergy And Infectious Diseases1992–1993
  • Suppressor T Cells Of Mixed Leukocyte Reaction In ManNational Cancer Institute1988–1992
  • National Cooperative Drug Discovery Group For AIDSNational Institute Of Allergy And Infectious Diseases1987–1991
  • Suppressor T Cells Of Mixed Leukocyte Reaction In ManNational Cancer Institute1985–1987
  • Immunologic Defects In Lepromatous LeprosyNational Institute Of Allergy And Infectious Diseases1985–1986
  • Detection Of The Carrier State Of AIDSNational Heart, Lung, And Blood Institute1985–1986
  • Monoclonal Antibodies To Lymphocyte Surface MoleculesNational Institute Of Allergy And Infectious Diseases1985
  • Studies Of The T-Cell Retrovirus Associated With AIDSNational Heart, Lung, And Blood Institute1985
  • Immunologic StudiesNational Heart, Lung, And Blood Institute1985
  • Core--Cell Sorter FacilityNational Heart, Lung, And Blood Institute1985
  • Mechanism Of Impairment Of Cell-Mediated ImmunityNational Cancer Institute1985

Hospital Affiliations

Dr. Edgar Engleman, Dr. Edgar Engleman, MD, Dr. E Engleman, Dr. Edgar George Engleman